But as youll hear tonight, breakthroughs like these are anything but overnight. The drugs such as Ozempic and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide) are transforming healthcare
Unlike traditional GLP-1 therapies, Retatrutide works by targeting three hormone receptors involved in appetite control, blood sugar regulation, and energy balance: GLP-1, GIP, and glucagon receptors
While GLP-1 receptors are present in the hippocampus and preclinical studies suggest potential cognitive benefits, there is currently no FDA-approved indication for GLP-1 medications in cognitive disorders or neuroprotection
Further evidence has increased the understanding of GIP showing that GIP likely still has a role in diabetes despite normal or sometimes elevated concentrations
Does FDA approval guarantee results
[PMID: 1681507] PubMed record related to this compound for laboratory literature review